Vitamin D and Immune Mechanisms of Hypertension in Type 2 Diabetics
Status: Recruiting
Location: See all (2) locations...
Intervention Type: Diagnostic test
Study Type: Observational
SUMMARY
This trial will evaluate whether a particular type of circulating white blood cell, monocytes, from type 2 diabetics with high blood pressure and vitamin D deficiency vs. sufficiency will induce hormones that increase blood pressure.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 25
Maximum Age: 80
View:
• Type 2 diabetes (T2DM)
• Age: 25-80 years old
• Vitamin 25(OH)D3 levels \<20 or \>30 ng/ml.
• HbA1c: 5.5%-9.5%
• Blood Pressure: \<160/100 mm Hg on BP lowering medications and
• Blood Pressure: \>120/80 to 160/100 mmHg without BP lowering medications
Locations
United States
Missouri
Barnes-Jewish & Washington University Diabetes Center
RECRUITING
St Louis
Washington University
RECRUITING
St Louis
Contact Information
Primary
Greta Kutz
cbernal@wustl.edu
3143629532
Backup
Amy E Riek, MD
ariek@wustl.edu
3143629532
Time Frame
Start Date: 2017-09-01
Estimated Completion Date: 2024-12-31
Participants
Target number of participants: 40
Treatments
Vitamin D Deficient
Type 2 diabetics with high blood pressure and 25-hydroxyvitamin D levels of \<20 ng/ml
Vitamin D Sufficient
Type 2 diabetics with high blood pressure and 25-hydroxyvitamin D levels of \>30 ng/ml
Related Therapeutic Areas
Sponsors
Leads: Washington University School of Medicine